Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration

Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration

Abstract Background The aim of this study is to analyze mortality in patients treated with bevacizumab for wet AMD. Methods We conducted a retrospective case-control study between patients who received intravitreal injections of bevacizumab as the sole treatment for exudative AMD between September 2...

Full description

Bibliographic Details
Main Authors: Joel Hanhart, Doron S. Comaneshter, Yossi Freier Dror, Shlomo Vinker
Format: Article
Language:English
Published: BMC 2017-10-01
Series:BMC Ophthalmology
Subjects:
Neovascular AMD
Anti-VEGF
Bevacizumab
Safety
Mortality
Online Access:http://link.springer.com/article/10.1186/s12886-017-0586-0

Internet

http://link.springer.com/article/10.1186/s12886-017-0586-0

Similar Items